Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The primary purpose of this study is to evaluate the safety and preliminary efficacy of microplasmin when administered intravenously to patients who have suffered an acute stroke within 12 hours before randomization.
Epistemonikos ID: 42795c33a1d8a2f51bf3525d68064112e7c31354
First added on: May 04, 2024